- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06380504
Increasing the Coverage of Severe Acute Malnutrition (SAM) Treatment in Ethiopia (R-SWITCH)
Effect of Leveraging Community-level Structures to Strengthen Prevention, Screening and Treatment of Severe Acute Malnutrition in Ethiopia
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Despite the high mortality risk of severe wasting (also referred to as severe acute malnutrition or SAM), only a small proportion of children with severe wasting are currently identified and admitted to available outpatient treatment programs (OTP). In 2020, an estimated 4.9 million children with severe wasting received treatment, approximately a third of the total burden. Outside of humanitarian settings, this proportion is even lower (estimated to be around 15%). These figures highlight the urgent need to increase treatment coverage to meet the Sustainable Development Goals (SDG), which aim to reduce the prevalence of child wasting to less than 5% by 2025 and less than 3% by 2030. The continuum of care for SAM, from case identification, referral to treatment, and post-treatment follow-up, is hampered by several barriers including caregiver lack of awareness on the risks and treatment services of SAM, stigma related to SAM, poor accessibility to treatment, frequent stockouts of treatment inputs, and the overall workload faced by first-line health workers.
The R-SWITCH intervention will leverage existing community groups to deliver an integrated package aimed at preventing SAM through behavior change communication (BCC) on child nutrition and health, increasing wasting screening coverage through active screening, family-led MUAC and improved passive screening health posts, increasing treatment coverage through follow-up of earlier referred cases, cases enrolled in OTP, and children who completed OTP and recovered.
The primary objectives of the R-SWITCH studies are:
- To assess the impact of the R-SWITCH intervention on SAM OTP coverage
- To identify implementation barriers and facilitators
- To assess the cost-efficiency and cost-effectiveness of the intervention package and services
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lieven Huybregts, PhD
- Phone Number: +1 202 862-6481
- Email: l.huybregts@cgiar.org
Study Contact Backup
- Name: Alemayehu Haddis, PhD
- Email: alemayehuh@etpha.org
Study Locations
-
-
-
Jimma, Ethiopia
- Recruiting
- Kersa and Jeldessa woredas
-
Principal Investigator:
- Lieven Huybregts, PhD
-
Principal Investigator:
- Tefera Belachew, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Child 6-59 months of age
- Suffering from SAM (defined as MUAC < 115mm or presence of bilateral pitting edema or Weight-for-Length Z-score <-3) OR currently enrolled in SAM OTP
Exclusion Criteria:
- Anthropometric malformation or being handicapped which hampers anthropometric measurements.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Standard of Care
|
|
|
Experimental: R-SWITCH integrated intervention package
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Period prevalence of SAM OTP treatment coverage in children 6-59 months of age
Time Frame: After 24 months of program implementation
|
Defined as the proportion of children with Severe Acute Malnutrition (SAM) or enrolled in the SAM Outpatient Therapeutic program (OTP) that are "under treatment".
|
After 24 months of program implementation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Point prevalence of SAM OTP treatment coverage in children 6-59 months of age
Time Frame: After 24 months of program implementation
|
Defined as the proportion of children with SAM at the time of the survey that are under treatment (see definition under primary outcome
|
After 24 months of program implementation
|
|
Period prevalence of SAM OTP treatment coverage in the subgroup of treatment eligible children 6-59 months of age
Time Frame: After 24 months of program implementation
|
Defined as the proportion of children with Severe Acute Malnutrition (SAM) or Severe underweight (weight-for-age Z-score <-3) or enrolled in the SAM Outpatient Therapeutic program (OTP) that are "under treatment".
|
After 24 months of program implementation
|
|
Screening coverage of SAM
Time Frame: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with SAM screened for wasting over the last 30 days (as reported by the caregiver)
|
After 24 months of program implementation
|
|
Screening coverage of severe underweight
Time Frame: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with severe underweight (weight-for-age Z-score <-3 relative to WHO 2006 growth standard) screened over the last 30 days (as reported by the caregiver)
|
After 24 months of program implementation
|
|
Platform specific screening coverage of SAM
Time Frame: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with SAM screened for wasting over the last 30 days (as reported by the caregiver):
|
After 24 months of program implementation
|
|
Growth Monitoring Promotion (GMP) consultation attendance
Time Frame: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with SAM that attended GMP over the last 30 days (as reported by the caregiver).
|
After 24 months of program implementation
|
|
AFD group meeting attendance
Time Frame: After 24 months of program implementation
|
Defined as the proportion of of children aged 6-59 months with SAM that attended the monthly AFD group contact over the last 30 days (as reported by the caregiver).
|
After 24 months of program implementation
|
|
AFD home visit coverage
Time Frame: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with SAM and children enrolled in SAM OTP that received a home visit by an AFD leader/member over the last 30 days (as reported by the caregiver).
|
After 24 months of program implementation
|
|
Prevalence of SAM
Time Frame: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with SAM (defined as WHZ <-3 or a MUAC < 115 mm or the presence of bilateral pitting edema).
To calculate WHZ scores the 2006 WHO growth reference will be used
|
After 24 months of program implementation
|
|
Prevalence of wasting
Time Frame: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with wasting (defined as WHZ <-2 or a MUAC < 125 mm or the presence of bilateral pitting edema).
To calculate WHZ scores the 2006 WHO growth reference will be used
|
After 24 months of program implementation
|
|
Prevalence of stunting
Time Frame: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with stunting (defined as height-for-age Z-scores (HAZ) <-2 or a MUAC < 125 mm or the presence of bilateral pitting edema).
To calculate HAZ scores the 2006 WHO growth reference will be used
|
After 24 months of program implementation
|
|
Prevalence of underweight and severe underweight
Time Frame: After 24 months of program implementation
|
Defined as the proportion of children aged 6-59 months with underweight (defined as weight-for-age Z-scores (WAZ) <-2 ) and severe underweight (defined as WAZ <-3 ).
To calculate WAZ scores the 2006 WHO growth reference will be used
|
After 24 months of program implementation
|
|
Mean height-for-age Z-score (HAZ)
Time Frame: After 24 months of program implementation
|
In 6-59 months old children.
To calculate HAZ scores the 2006 WHO growth reference will be used
|
After 24 months of program implementation
|
|
Mean weight-for-height Z-score (WHZ)
Time Frame: After 24 months of program implementation
|
In 6-59 months old children.To calculate WHZ scores the 2006 WHO growth reference will be used
|
After 24 months of program implementation
|
|
Mean weight-for-age Z-score (WAZ)
Time Frame: After 24 months of program implementation
|
In 6-59 months old children.To calculate WAZ scores the 2006 WHO growth reference will be used
|
After 24 months of program implementation
|
|
Mean mid-upper arm circumference (MUAC)
Time Frame: After 24 months of program implementation
|
In 6-59 months old children.
|
After 24 months of program implementation
|
|
Caregiver's knowledge related to breastfeeding, complementary feeding,child health and hygiene, the condition of severe acute malnutrition, outpatient therapeutic programs, screening of wasting
Time Frame: After 24 months of program implementation
|
Presented as a total standardized score and by knowledge domain
|
After 24 months of program implementation
|
|
Vaccination coverage
Time Frame: After 24 months of program implementation
|
Proportion of children aged 6-18 months with SAM or enrolled in SAM OTP who received all age-recommended immunizations
|
After 24 months of program implementation
|
|
Introduction of (semi) solid and soft complementary foods
Time Frame: After 24 months of program implementation
|
The proportion of children 6-8 months of age who consumed (semi) solid and soft complementary foods during the previous day
|
After 24 months of program implementation
|
|
Minimum dietary diversity in infants and young children (6-23 mo)
Time Frame: After 24 months of program implementation
|
The proportion of study children aged 6-23 months who consumed at least 5 of the 8 food groups (including breast milk) during the previous day
|
After 24 months of program implementation
|
|
Nr of food groups consumed by infants and young children (6-59 mo)
Time Frame: After 24 months of program implementation
|
The mean number of food groups consumed during the previous day by study children aged 6-59
|
After 24 months of program implementation
|
|
Minimum meal frequency in infants and young children
Time Frame: After 24 months of program implementation
|
Defined as the proportion of study children who had eaten during the previous day: 2 meals for breastfed children 6-8 months, 3 meals for breastfed children 9-23 months, or 4 meals for non-breastfed children 6-23 monthsMinimum meal frequency for children, defined as the proportion of children who had eaten the day before the survey: 2 meals for breastfed children 6-8 months, 3 meals for breastfed children 9-23 months, or 4 meals for non-breastfed children 6-23 months.
|
After 24 months of program implementation
|
|
Minimum acceptable diet in infants and young children
Time Frame: After 24 months of program implementation
|
Defined as the proportion of study children aged 6-23 months with both minimal dietary diversity and minimal meal frequency during the previous day
|
After 24 months of program implementation
|
|
Continuous breastfeeding 12-23 months
Time Frame: After 24 months of program implementation
|
Defined as the proportion of children aged 12-23 months breastfed during the previous day
|
After 24 months of program implementation
|
|
Egg and/or flesh food consumption
Time Frame: After 24 months of program implementation
|
Proportion of children 6-23 months of age who consumed egg and/or flesh food during the previous day
|
After 24 months of program implementation
|
|
Sweet beverage consumption
Time Frame: After 24 months of program implementation
|
Proportion of children 6-23 months of age who consumed a sweet beverage during the previous day
|
After 24 months of program implementation
|
|
Zero vegetable or fruit consumption consumption
Time Frame: After 24 months of program implementation
|
Proportion of children 6-23 months of age who did not consume any vegetables or fruits during the previous day
|
After 24 months of program implementation
|
|
Minimum milk feeding frequency for non-breastfed children
Time Frame: After 24 months of program implementation
|
Proportion of non-breastfed children 6-23 months of age who consumed at least two milk feeds during the previous day
|
After 24 months of program implementation
|
|
Weight-for-length Z-score and MUAC at Severe Acute Malnutrition (SAM) Outpatient Therapeutic Feeding program (OTP)
Time Frame: 24 months from baseline until endline of the study
|
Weight-for-length Z-score (relative to the 2006 WHO reference) and MUAC(mm)
|
24 months from baseline until endline of the study
|
|
SAM OTP adherence
Time Frame: 24 months from baseline until endline of the study
|
Defined as the proportion of cases enrolled to SAM OTP who received timely treatment from dedicated services (health center or health post) until anthropometric recovery
|
24 months from baseline until endline of the study
|
|
Weight gain rate during SAM OTP
Time Frame: 24 months from baseline until endline of the study
|
Defined as the weight gain during SAM OTP divided by the length of treatment and divided by the child's weight
|
24 months from baseline until endline of the study
|
|
SAM OTP outcomes (drop-out, death, transfer, non-response rates)
Time Frame: 24 months from baseline until endline of the study
|
Among cases admitted to SAM OTP
|
24 months from baseline until endline of the study
|
|
SAM OTP duration
Time Frame: 24 months from baseline until endline of the study
|
Defined as the number of days spent in SAM OTP (from admission to discharge)
|
24 months from baseline until endline of the study
|
Collaborators and Investigators
Investigators
- Principal Investigator: Lieven Huybregts, PhD, International Food Policy Research Institute
- Principal Investigator: Tefera Belachew, PhD, Ethiopian Public Health Association
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RSWITCH-Ethiopia
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wasting
-
National Taiwan University HospitalUnknownMalnutrition | Body Composition | Nutritional WastingTaiwan
-
National Taiwan University HospitalCompleted
-
National Taiwan University HospitalUnknownPeritoneal Dialysis | Wasting and MalnutritionTaiwan
-
The Hospital for Sick ChildrenMinistry of Health, Malawi; Nutriset; Schlumberger Foundation; Friends of Sick...CompletedSevere Acute Malnutrition | Severe WastingMalawi
-
Johns Hopkins UniversityWithdrawn
-
Assiut UniversityNot yet recruitingChronic Wasting Disease of Elk and Deer | Injury; Knee, Meniscus, Old Injury or Tear
-
Wageningen UniversityGelderse Vallei HospitalRecruitingMuscle Wasting in Critically IllNetherlands
-
University Hospital, Basel, SwitzerlandRecruitingMuscle Wasting in Critically IllSwitzerland
-
NYU Langone HealthWithdrawnSIADH | Cerebral Hyponatremia | Cerebral Salt-wasting Syndrome | Reset Hypothalamic OsmostatUnited States
-
Hospital Civil Juan I. MenchacaNot yet recruitingMalnutrition | Peritoneal Dialysis | Oxidative Stress | Protein-Energy Malnutrition | Protein-Energy Wasting | Oral Nutritional Supplements
Clinical Trials on R-SWITCH integrated intervention package
-
International Food Policy Research InstituteUNICEF; Kenyatta UniversityRecruitingWasting | Malnutrition, Child | Acute Malnutrition, SevereKenya
-
Makerere UniversityCentre For International HealthCompletedPreterm Birth | Neonatal Death | Low Birthweight | Neonatal HypoglycemiaUganda
-
Nanchang UniversityXiangdong District General Hospital; Xinfeng County Center for Disease Control... and other collaboratorsNot yet recruitingHypertension | Comorbidities and Coexisting Conditions | Diabete Type 2
-
Johns Hopkins Bloomberg School of Public HealthJhpiego; Gavi, The Vaccine Alliance; Direct Consulting and LogisticsCompletedHuman Papillomavirus (HPV) Infections | Adolescent Health Services | Human Papillomavirus (HPV) Vaccines | Human Papillomavirus (HPV) VaccineNigeria
-
Fabian RohnerChildren's Investment Fund Foundation; One Acre FundCompleted
-
University of Cape TownWithdrawnFollow-up Study | Medical In-patientsSouth Africa
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...Not yet recruitingPeriodontal Diseases | Pregnancy | Oral Hygiene, Oral HealthBangladesh
-
Azienda Ospedaliera San Gerardo di MonzaGilead SciencesCompletedQuality of Life | HIV-1 Infection | Impaired Cognition | Poor Quality Sleep | Depression/AnxietyItaly
-
The University of QueenslandNational Health and Medical Research Council, AustraliaCompletedObesity | Hearing Impairment | Vision ImpairmentAustralia
-
Aga Khan UniversityImperial College London; Wellcome TrustCompletedOccupational Diseases | Occupational Lung DiseasePakistan